BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus

OBJECTIVES: Our aim was to evaluate systemic lupus erythematosus (SLE) disease activity and SARS-CoV-2-specific immune responses after BNT162b2 vaccination. METHODS: In this prospective study, disease activity and clinical assessments were recorded from the first dose of vaccine until day 15 after t...

Descripción completa

Detalles Bibliográficos
Autores principales: Moyon, Quentin, Sterlin, Delphine, Miyara, Makoto, Anna, François, Mathian, Alexis, Lhote, Raphael, Ghillani-Dalbin, Pascale, Breillat, Paul, Mudumba, Sasi, de Alba, Sophia, Cohen-aubart, Fleur, Haroche, Julien, Pha, Micheline, Boutin, Thi Huong Du, Chaieb, Hedi, Flores, Pedro Macedo, Charneau, Pierre, Gorochov, Guy, Amoura, Zahir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494536/
https://www.ncbi.nlm.nih.gov/pubmed/34607791
http://dx.doi.org/10.1136/annrheumdis-2021-221097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494536/
https://www.ncbi.nlm.nih.gov/pubmed/34607791
http://dx.doi.org/10.1136/annrheumdis-2021-221097

Ejemplares similares